In a statement published one month earlier confirmation of first monkeypox case in France, the HAS detailed the new vaccine dose should not be applied to immunosuppressed individuals.

HAS, likewise, envisaged protecting children exposed to the new virus and also sensitive to developing a severe form of the disease.

In may, the HAS strongly recommended vaccinating adults at high risk of catching monkeypox, a contagious disease with early symptoms including fever, headache, muscle aches, chills and swollen lymph nodes, resulting in possible rashes (three days later) on face and whole body. pll/rgh/wmr